ÂÜÀòÂÒÂ×

After completing his Ph.D. in 1995 in the field of biomedical engineering at The University of Texas Southwestern Medical Center in Dallas, Kevin joined the faculty at The University of Texas at Arlington where he earned tenure in 2003 and resigned in 2005 to become a full-time Founder and Chief Scientific Officer of TissueGen, Inc. He is an inventor on numerous patents that comprise the foundation of TissueGen's technology in the areas of drug protection and delivery. He continues to keep close to the university and currently serves as the head of the bioengineering industrial advisory board.